These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10097919)

  • 21. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.
    Winnock F; Christie MR; Batstra MR; Aanstoot HJ; Weets I; Decochez K; Jopart P; Nicolaij D; Gorus FK;
    Diabetes Care; 2001 Jul; 24(7):1181-6. PubMed ID: 11423499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in Korea.
    Kim CS; Nam JH; Nam JS; Park JS; Kang ES; Ahn CW; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
    Metabolism; 2006 Aug; 55(8):1107-12. PubMed ID: 16839848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population.
    Krochik AG; Mazza CS; Valdez SN; Stumpo RR; Papouchado ML; Iacono RF; Cardoso Landaburu AC; Sica MP; Ozuna B; Poskus E
    Medicina (B Aires); 2001; 61(3):279-83. PubMed ID: 11474874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
    Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
    Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Autoimmune insulitis in patients with type 2 diabetes mellitus A randomized clinical trial in hospitalized patients].
    Martinka E; Rončáková M; Mišániková M; Davani A
    Vnitr Lek; 2016; 62(7-8):521-33. PubMed ID: 27627073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Islet cell-associated autoantibodies in Ethiopians with diabetes mellitus.
    Siraj ES; Gupta MK; Yifter H; Ahmed A; Kebede T; Reja A; Abdulkadir J
    J Diabetes Complications; 2016 Aug; 30(6):1039-42. PubMed ID: 27220543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7).
    Zampetti S; Campagna G; Tiberti C; Songini M; Arpi ML; De Simone G; Cossu E; Cocco L; Osborn J; Bosi E; Giorgino F; Spoletini M; Buzzetti R;
    Eur J Endocrinol; 2014 Dec; 171(6):697-704. PubMed ID: 25213702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
    Dittler J; Seidel D; Schenker M; Ziegler AG
    Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.
    Arikan E; Sabuncu T; Ozer EM; Hatemi H
    J Diabetes Complications; 2005; 19(5):254-8. PubMed ID: 16112499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.
    Andersson C; Kolmodin M; Ivarsson SA; Carlsson A; Forsander G; Lindblad B; Ludvigsson J; Kockum I; Marcus C; Samuelsson U; Ortqvist E; Lernmark A; Elding Larsson H; Törn C;
    Pediatr Diabetes; 2014 Aug; 15(5):336-44. PubMed ID: 24206368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GAD 65 antibody but not ICA positivity in adult-onset diabetic patients is associated with early progression to clinical insulin dependency.
    Hatziagelaki E; Jaeger C; Maeser E; Bretzel RG; Federlin K
    Acta Diabetol; 1996 Dec; 33(4):291-4. PubMed ID: 9033970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes mellitus among young adults in Sri Lanka--role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes study.
    Katulanda P; Shine B; Katulanda GW; Silva A; Asfir EL; Sheriff R; Somasundaram N; Long AE; Bingley PJ; McCarthy MI; Clark A; Matthews DR
    Diabetologia; 2008 Aug; 51(8):1368-74. PubMed ID: 18528678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of positive rates between glutamic acid decarboxylase antibodies and ElisaRSR™ 3 Screen ICA™ in recently obtained sera from patients who had been previously diagnosed with slowly progressive type 1 diabetes.
    Takehana N; Fukui T; Mori Y; Hiromura M; Terasaki M; Ohara M; Takada M; Tomoyasu M; Ito Y; Kobayashi T; Yamagishi SI
    J Diabetes Investig; 2023 Jul; 14(7):856-863. PubMed ID: 37082800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group.
    Knip M; Karjalainen J; Akerblom HK
    Diabetes Care; 1998 Oct; 21(10):1670-3. PubMed ID: 9773728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutamic acid decarboxylase65 (GAD65) antibodies and insulin auto-antibodies in Japanese patients with non-insulin-dependent diabetes mellitus.
    Maruyama T; Kasuga A; Ozawa Y; Nagata A; Abiko F; Suzuki Y; Saruta T
    Endocr J; 1997 Feb; 44(1):43-51. PubMed ID: 9152613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of antibodies against glutamic acid decarboxylase 65 (GADA): two new 125I assays compared with [35S]GAD 65-ligand binding assay.
    Borg H; Fernlund P; Sundkvist G
    Clin Chem; 1997 May; 43(5):779-85. PubMed ID: 9166231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antibodies to glutamic acid decarboxylase (GADA) as markers of risk for development of insulin-dependent diabetes mellitus].
    Kretowski A; Szelachowska M; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 1998; 55(6):315-9. PubMed ID: 9857706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives.
    Pastore MR; Bazzigaluppi E; Bonfanti R; Dozio N; Sergi A; Balini A; Belloni C; Meschi F; Bonifacio E; Bosi E
    Diabetes Care; 1998 Sep; 21(9):1445-50. PubMed ID: 9727889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subtle hyperproinsulinaemia characterises the defective insulin secretory capacity in offspring of glutamic acid decarboxylase antibody-positive patients with latent autoimmune diabetes mellitus in adults.
    Vauhkonen I; Niskanen L; Knip M; Mykkänen LM; Haffner S; Uusitupa M; Laakso M
    Eur J Endocrinol; 2005 Aug; 153(2):265-73. PubMed ID: 16061833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies].
    Yang L; Zhou ZG; Huang G; Yan X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):309-14. PubMed ID: 16136967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.